SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-004190
Filing Date
2024-01-16
Accepted
2024-01-16 18:36:17
Documents
1
Period of Report
2023-12-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm243463-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm243463-1_3seq1.xml 3 1531
  Complete submission text file 0001104659-24-004190.txt   3100
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1201 ORANGE STREET, SUITE 600 WILMINGTON DE 19801
Business Address
Rehnquist Janet (Reporting) CIK: 0002008290 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38302 | Film No.: 24536363